Display options
Cite
Ankrah D, Owusu H, Aggor A, et al. Point Prevalence Survey of Antimicrobial Utilization in Ghana's Premier Hospital: Implications for Antimicrobial Stewardship. Antibiotics (Basel). 2021;10(12)doi: 10.3390/antibiotics10121528.
Ankrah, D., Owusu, H., Aggor, A., Osei, A., Ampomah, A., Harrison, M., Nelson, F., Aboagye, G. O., Ekpale, P., Laryea, J., Selby, J., Amoah, S., Lartey, L., Addison, O., Bruce, E., Mahungu, J., & Mirfenderesky, M. (2021). Point Prevalence Survey of Antimicrobial Utilization in Ghana's Premier Hospital: Implications for Antimicrobial Stewardship. Antibiotics (Basel, Switzerland), 10(12), . https://doi.org/10.3390/antibiotics10121528
Ankrah, Daniel, et al. "Point Prevalence Survey of Antimicrobial Utilization in Ghana's Premier Hospital: Implications for Antimicrobial Stewardship." Antibiotics (Basel, Switzerland) vol. 10,12 (2021). doi: https://doi.org/10.3390/antibiotics10121528
Ankrah D, Owusu H, Aggor A, Osei A, Ampomah A, Harrison M, Nelson F, Aboagye GO, Ekpale P, Laryea J, Selby J, Amoah S, Lartey L, Addison O, Bruce E, Mahungu J, Mirfenderesky M. Point Prevalence Survey of Antimicrobial Utilization in Ghana's Premier Hospital: Implications for Antimicrobial Stewardship. Antibiotics (Basel). 2021 Dec 14;10(12). doi: 10.3390/antibiotics10121528. PMID: 34943740; PMCID: PMC8698913.
Copy Download .nbib Format: NLM
Share it on

Antibiotics (Basel). 2021 Dec 14;10(12). doi: 10.3390/antibiotics10121528.

Point Prevalence Survey of Antimicrobial Utilization in Ghana's Premier Hospital: Implications for Antimicrobial Stewardship.

Antibiotics (Basel, Switzerland)

Daniel Ankrah, Helena Owusu, Asiwome Aggor, Anthony Osei, Agneta Ampomah, Mark Harrison, Frempomaa Nelson, Grace Owusu Aboagye, Priscilla Ekpale, Jennifer Laryea, Julia Selby, Serwaa Amoah, Linda Lartey, Okaikor Addison, Elizabeth Bruce, Joyce Mahungu, Mariyam Mirfenderesky

Affiliations

  1. Korle-Bu Teaching Hospital, Accra GA-221-1570, Ghana.
  2. North Middlesex University Hospital NHS Trust, London N18 1QX, UK.

PMID: 34943740 PMCID: PMC8698913 DOI: 10.3390/antibiotics10121528

Abstract

The first comprehensive point prevalence survey at the Korle Bu Teaching Hospital (KBTH) was performed as part of the 2019 Global Point Prevalence Survey (Global-PPS) on antimicrobials. The aim was to establish a PPS baseline for the whole hospital and to identify required stewardship interventions. The PPS was conducted over three days in June 2019 using the GLOBAL-PPS standardized method for surveillance of antimicrobial utilization in hospitals to evaluate antimicrobial prescribing. In all, 988 patients were admitted to 69 wards. Overall antimicrobial prevalence was 53.3%. More community-acquired infections (CAI) were treated empirically compared to health-care associated infections (94.0% vs. 86.1% respectively,

Keywords: CwPAMS; Ghana; Korle Bu Teaching Hospital; antimicrobial stewardship; point prevalence survey

References

  1. J Pediatric Infect Dis Soc. 2015 Mar;4(1):11-20 - PubMed
  2. Lancet Infect Dis. 2014 Aug;14(8):742-750 - PubMed
  3. Cochrane Database Syst Rev. 2013 Apr 30;(4):CD003543 - PubMed
  4. Antibiotics (Basel). 2014 Sep 10;3(3):450-60 - PubMed
  5. Trans R Soc Trop Med Hyg. 2011 Nov;105(11):667-9 - PubMed
  6. Sex Transm Dis. 2014 Apr;41(4):233-7 - PubMed
  7. BMJ. 2012 Apr 03;344:e1567 - PubMed
  8. Infect Drug Resist. 2011;4:215-20 - PubMed
  9. J Hosp Infect. 2020 Feb;104(2):165-171 - PubMed
  10. Lancet Infect Dis. 2017 Sep;17(9):990-1001 - PubMed
  11. PLoS One. 2017 May 3;12(5):e0175689 - PubMed
  12. Pharmacoepidemiol Drug Saf. 2002 Jul-Aug;11(5):361-72 - PubMed
  13. Clin Infect Dis. 2007 Sep 15;45 Suppl 3:S171-6 - PubMed
  14. Infect Drug Resist. 2015 Nov 18;8:379-89 - PubMed
  15. Vaccine. 2015 Jun 19;33 Suppl 3:C21-9 - PubMed
  16. Gut. 2013 Jan;62(1):34-42 - PubMed
  17. Lancet. 2005 Feb 12-18;365(9459):579-87 - PubMed
  18. Arch Intern Med. 2000 Jan 10;160(1):98-104 - PubMed
  19. Harm Reduct J. 2009 Nov 19;6:31 - PubMed
  20. Clin Infect Dis. 2016 May 15;62(10):e51-77 - PubMed
  21. Antimicrob Resist Infect Control. 2020 Jan 13;9(1):13 - PubMed
  22. N Engl J Med. 2006 Aug 17;355(7):666-74 - PubMed
  23. J Antimicrob Chemother. 2014 Sep;69(9):2337-53 - PubMed
  24. Int J Antimicrob Agents. 2014 Apr;43(4):301-9 - PubMed
  25. J Res Pharm Pract. 2019 Oct 16;8(3):149-154 - PubMed
  26. JAC Antimicrob Resist. 2020 Feb 18;2(1):dlaa001 - PubMed
  27. J Antimicrob Chemother. 1999 Apr;43(4):459-65 - PubMed
  28. Lancet Infect Dis. 2016 Jul;16(7):847-856 - PubMed
  29. Lancet Glob Health. 2018 Jun;6(6):e619-e629 - PubMed
  30. BMC Med. 2014 Mar 06;12:40 - PubMed
  31. Antimicrob Resist Infect Control. 2018 Jan 26;7:15 - PubMed
  32. J Antimicrob Chemother. 2002 Apr;49(4):661-6 - PubMed
  33. Ann Afr Med. 2019 Jul-Sep;18(3):132-137 - PubMed
  34. Infect Control Hosp Epidemiol. 2008 Jul;29(7):615-22 - PubMed
  35. West Afr J Med. 2009 Sep-Oct;28(5):300-3 - PubMed
  36. Antibiotics (Basel). 2021 Feb 18;10(2): - PubMed
  37. Expert Rev Anti Infect Ther. 2019 Jul;17(7):535-546 - PubMed

Publication Types

Grant support